MahlerDA, SeleckyPA, HarrodCG, BendittJO, Carrieri-KohlmanV, CurtisJR, ManningHL, MularskiRA, VarkeyB, CampbellM, CarterER, ChiongJR, ElyEW, Hansen-FlaschenJ, O'DonnellDE, WallerA. American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest, 2010; 137:674–691.
2.
ViolaR, KiteleyC, LloydNS, MackayJA, WilsonJ, WongRK. Supportive Care Guidelines Group of the Cancer Care Ontario Program in Evidence-Based Care. The management of dyspnea in cancer patients: A systematic review. Support Care Cancer, 2008; 16:329–337.
3.
JenningsAL, DaviesAN, HigginsJP, BroadleyK. Opioids for the palliation of breathlessness in terminal illness. Cochrane Database Syst Rev, 2001; 4:CD002066.
4.
ClemensKE, KlaschikE. Dyspnoea associated with anxiety—symptomatic therapy with opioids in combination with lorazepam and its effect on ventilation in palliative care patients. Support Care Cancer, 2010; 19:2027–2033.
5.
ClemensKE, QuednauI, KlaschikE. Use of oxygen and opioids in the palliation of dyspnoea in hypoxic and non-hypoxic palliative care patients: A prospective study. Support Care Cancer, 2009; 17:367–377.
6.
ClemensKE, KlaschikE. Effect of hydromorphone on ventilation in palliative care patients with dyspnea. Support Care Cancer, 2008; 16:93–99.
7.
ClemensKE, KlaschikE. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients. J Pain Symptom Manage, 2007; 33:473–481.
8.
EstfanB, MahmoudF, ShaheenP, DavisMP, LasheenW, RiveraN, LegrandSB, LagmanRL, WalshD, RybickiL. Respiratory function during parenteral opioid titration for cancer pain. Palliat Med, 2007; 21:81–86.
9.
AllenS, RautS, WoollardJ, VassalloM. Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis. Palliat Med, 2005; 19:128–130.
10.
DavisMP, WeissmanDE, ArnoldRM. Opioid dose titration for severe cancer pain: a systematic evidence-based review. J Palliat Med, 2004; 7:462–468.
11.
WalshTD, RiveraNI, KaikoR. Oral morphine and respiratory function amongst hospice inpatients with advanced cancer. Support Care Cancer, 2003; 11:780–784.
12.
PernaG, CaldirolaD, NamiaC, CucchiM, VanniG, BellodiL. Language of dyspnea in panic disorder. Depress Anxiety, 2004; 20:32–38.
13.
BeachD, SchwartzsteinRM. The genesis of breathlessness: What do we understand?BoothS. DudgeonD. Dyspnoea in Advanced Disease. Oxford, UK: Oxford University Press, 2006; 1–18.
14.
SimonPM, SkatrudJB, BadrMS, GriffinDM, IberC, DempseyJA. Role of airway mechanoreceptors in the inhibition of inspiration during mechanical ventilation in humans. Am Rev Respir Dis, 1991; 144:1033–1041.
15.
ManningHL, SchwartzsteinRM. Pathophysiology of dyspnea. N Engl J Med, 1995; 333:1547–1553.
16.
BanzettRB, LansingRW, ReidMB, AdamsL, BrownR. 'Air hunger' arising from increased PCO2 in mechanically ventilated quadriplegics. Respir Physiol, 1989; 76:53–67.
17.
BanzettRB, LansingRW, BrownR, TopulosGP, YagerD, SteeleSM, LondoñoB, LoringSH, ReidMB, AdamsL, NationsCS. ‘Air hunger' from increased PCO2 persists after complete neuromuscular block in humans. Respir Physiol, 1990; 81:1–17.
18.
BuchananGF, RichersonGB. Role of chemoreceptors in mediating dyspnea. Respir Physiol Neurobiol, 2009; 167:9–19.
19.
WiseRA, PolitoAJ, KrishnanV. Respiratory physiologic changes in pregnancy. Immunol Allergy Clin North Am, 2006; 26:1–12.
20.
ContrerasG, GutiérrezM, BeroízaT, FantínA, OddóH, VillarroelL, CruzE, LisboaC. Ventilatory drive and respiratory muscle function in pregnancy. Am Rev Respir Dis, 1991; 144:837–841.
21.
Garcia-RioF, PinoJM, GómezL, Alvarez-SalaR, VillasanteC, VillamorJ. Regulation of breathing and perception of dyspnea in healthy pregnant women. Chest, 1996; 110:446–453.
22.
SpathisA, WadeR, BoothS. Oxygen in the palliation of breathlessness. BoothS. DudgeonD. Dyspnoea in Advanced Disease. Oxford, UK: University Press, 2006; 206–236.
23.
WatanabeS. The role of oxygen in cancer-related dyspnea. PortenoyR. BrueraE. Topics in Palliative Care. New York: Oxford University Press, 2000; 255–260.
24.
LibbyD, BriscoeW, KingTK. Relief of hypoxia-related bronchoconstriction by breathing 30 percent oxygen. Am Rev Respir Dis, 1981; 123:171–175.
25.
LissH, GrantB. The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis, 1988; 137:1285–1288.
26.
BurkiNK, LeeLY. Mechanisms of dyspnea. Chest, 2010; 138:1196–1201.
27.
SchwartzsteinRM, LahiveK, PopeA, WeinbergerSE, WeissJW. Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis, 1987; 136:58–61.
28.
BurgessKR, WhitelawWA. Reducing ventilatory response to carbon dioxide by breathing cold air. Am Rev Respir Dis, 1984; 129:687–690.
29.
SpenceDP, GrahamDR, AhmedJ, ReesK, PearsonMG, CalverleyPM. Does cold air affect exercise capacity and dyspnea in stable chronic obstructive pulmonary disease?Chest, 1993; 103:693–696.
30.
SibuyaM, YamadaM, KanamaruA, TanakaK, SuzukiH, NoguchiE, AltoseMD, HommaI. Effect of chest wall vibration on dyspnea in patients with chronic respiratory disease. Am J Respir Crit Care Med, 1994; 149:1235–1240.
31.
FujieT, TojoN, InaseN, NaraN, HommaI, YoshizawaY. Effect of chest wall vibration on dyspnea during exercise in chronic obstructive pulmonary disease. Respir Physiol Neurobiol, 2002; 130:305–316.
32.
ScanoG, Innocenti-BruniG, StendardiL. Do obstructive and restrictive lung diseases share common underlying mechanisms of breathlessness?Respir Med, 2010; 104:925–933.
33.
SmollerJW, PollackMH, OttoMW, RosenbaumJF, KradinRL. Panic anxiety, dyspnea, and respiratory disease. Theoretical and clinical considerations. Am J Respir Crit Care Med, 1996; 154:6–17.
SchwartzsteinRM, SimonPM, WeissJW, FenclV, WeinbergerSE. Breathlessness induced by dissociation between ventilation and chemical drive. Am Rev Respir Dis, 1989; 139:1231–1237.
36.
BrueraE, MacmillanK, PitherJ, MacDonaldRN. Effects of morphine on the dyspnea of terminal cancer patients. J Pain Symptom Manage, 1990; 5:341–344.
37.
MazzocatoC, BuclinT, RapinCH. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: A randomized double-blind controlled trial. Ann Oncol, 1999; 10:1511–1514.
38.
HallenbeckJ. Palliative Care Perspectives. New York: Oxford University Press, 2003.
39.
PattinsonKT. Opioids and the control of respiration. Br J Anaesth, 2008; 100:747–758.
40.
DaviesBL, BrundageCM, HarrisMB, TaylorBE. Lung respiratory rhythm and pattern generation in the bullfrog: role of neurokinin-1 and mu-opioid receptors. J Comp Physiol B, 2009; 179:579–592.
41.
VasilakosK, WilsonRJ, KimuraN, RemmersJE. Ancient gill and lung oscillators may generate the respiratory rhythm of frogs and rats. J Neurobiol, 2005; 62:369–385.
42.
KinkeadR. Phylogenetic trends in respiratory rhythmogenesis: Insights from ectothermic vertebrates. Respir Physiol Neurobiol, 2009; 168:39–48.
SinhaSS, GoetzR, KleinDF. Physiological and behavioral effects of naloxone and lactate in normal volunteers with relevance to the pathophysiology of panic disorder. Psychiatry Res, 2007; 149:309–314.
45.
GiffordAH, MahlerDA, WatermanLA, WardJ, KraemerWJ, KupchakBR, BairdJC. Neuromodulatory effect of endogenous opioids on the intensity and unpleasantness of breathlessness during resistive load breathing in COPD. COPD, 2011; 8:160–166.
46.
MahlerDA, MurrayJA, WatermanLA, WardJ, KraemerWJ, ZhangX, BairdJC. Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD. Eur Respir J, 2009; 33:771–77.
47.
LonerganT, GoodchildAK, ChristieMJ, PilowskyPM. Mu opioid receptors in rat ventral medulla: Effects of endomorphin-1 on phrenic nerve activity. Respir Physiol Neurobiol, 2003; 138:165–178.
48.
MustapicS, RadocajT, SanchezA, DogasZ, StuckeAG, HoppFA, StuthEA, ZuperkuEJ. Clinically relevant infusion rates of mu-opioid agonist remifentanil cause bradypnea in decerebrate dogs but not via direct effects in the pre-Botzinger complex region. J Neurophysiol, 2009; 103:409–418.
49.
BallanyiK, RuangkittisakulA, OnimaruH. Opioids prolong and anoxia shortens delay between onset of preinspiratory (pFRG) and inspiratory (preBotC) network bursting in newborn rat brainstems. Pflugers Arch, 2009; 458,3:571–587.
LalleyPM. Opioidergic and dopaminergic modulation of respiration. Respir Physiol Neurobiol, 2008; 164:160–167.
52.
MildhLH, LeinoKA, KirvelaOA. Effects of tramadol and meperidine on respiration, plasma catecholamine concentrations, and hemodynamics. J Clin Anesth, 1999; 11:310–316.
53.
BorgbjergFM, NielsenK, FranksJ. Experimental pain stimulates respiration and attenuates morphine-induced respiratory depression: a controlled study in human volunteers. Pain, 1996; 64:123–128.
54.
TemelJS, GreerJA, MuzikanskyA, GallagherER, AdmaneS, JacksonVA, DahlinCM, BlindermanCD, JacobsenJ, PirlWF, BillingsJA, LynchTJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med, 2010; 363:733–742.
